Kyle Elrod

752 total citations
23 papers, 606 citations indexed

About

Kyle Elrod is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Kyle Elrod has authored 23 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Genetics and 8 papers in Hematology. Recurrent topics in Kyle Elrod's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Chemical Synthesis and Analysis (6 papers). Kyle Elrod is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Chemical Synthesis and Analysis (6 papers). Kyle Elrod collaborates with scholars based in United States, United Kingdom and Switzerland. Kyle Elrod's co-authors include James W. Janc, William R. Moore, Lynne Cregar, William M. Abraham, Steve Sideris, Richard D. Tanaka, Paul A. Sprengeler, B.A. Katz, Roopa Rai and Petr Kuzmič and has published in prestigious journals such as Journal of the American Chemical Society, Blood and Journal of Molecular Biology.

In The Last Decade

Kyle Elrod

23 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle Elrod United States 14 269 145 119 110 108 23 606
Austin Vogt United States 11 517 1.9× 164 1.1× 43 0.4× 34 0.3× 65 0.6× 19 768
S. Maignan France 12 786 2.9× 105 0.7× 55 0.5× 160 1.5× 43 0.4× 13 1.2k
Verónica Alcolea Spain 12 342 1.3× 236 1.6× 80 0.7× 232 2.1× 164 1.5× 19 851
J.P. Guilloteau France 13 652 2.4× 100 0.7× 52 0.4× 156 1.4× 33 0.3× 17 1.0k
Igor Mochalkin United States 18 510 1.9× 121 0.8× 43 0.4× 171 1.6× 44 0.4× 26 1.0k
Mark Watson Canada 5 752 2.8× 64 0.4× 74 0.6× 65 0.6× 109 1.0× 6 967
Wentao Fu United States 15 474 1.8× 109 0.8× 73 0.6× 127 1.2× 146 1.4× 25 1.4k
Wolfgang von der Saal Germany 16 423 1.6× 228 1.6× 106 0.9× 357 3.2× 19 0.2× 35 959
J. Courtland White United States 17 664 2.5× 186 1.3× 90 0.8× 107 1.0× 60 0.6× 41 1.3k
Paulo Boschcov Brazil 12 253 0.9× 36 0.2× 82 0.7× 55 0.5× 83 0.8× 23 533

Countries citing papers authored by Kyle Elrod

Since Specialization
Citations

This map shows the geographic impact of Kyle Elrod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Elrod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Elrod more than expected).

Fields of papers citing papers by Kyle Elrod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle Elrod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Elrod. The network helps show where Kyle Elrod may publish in the future.

Co-authorship network of co-authors of Kyle Elrod

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle Elrod. A scholar is included among the top collaborators of Kyle Elrod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle Elrod. Kyle Elrod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, James Y., Kelly M. McKenna, Lynette Brown, et al.. (2018). RBC-Specific CD47 Pruning Confers Protection and Underlies the Transient Anemia in Patients Treated with Anti-CD47 Antibody 5F9. Blood. 132(Supplement 1). 2327–2327. 14 indexed citations
2.
Young, Wendy B., Joyce Mordenti, William D. Shrader, et al.. (2006). Factor VIIa inhibitors: Chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model. Bioorganic & Medicinal Chemistry Letters. 16(7). 2037–2041. 24 indexed citations
3.
Young, Wendy B., Roopa Rai, William D. Shrader, et al.. (2006). Small molecule inhibitors of plasma kallikrein. Bioorganic & Medicinal Chemistry Letters. 16(7). 2034–2036. 8 indexed citations
4.
Young, Wendy B., Paul A. Sprengeler, William D. Shrader, et al.. (2005). Generation of potent coagulation protease inhibitors utilizing zinc-mediated chelation. Bioorganic & Medicinal Chemistry Letters. 16(3). 710–713. 9 indexed citations
5.
Katz, B.A., Kyle Elrod, Erik Verner, et al.. (2003). Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-directed Serine Protease Inhibitors. Journal of Molecular Biology. 329(1). 93–120. 30 indexed citations
6.
Selwood, Trevor, Kyle Elrod, & Norman M. Schechter. (2003). Potent Bivalent Inhibition of Human Tryptase-? by a Synthetic Inhibitor. Biological Chemistry. 384(12). 1605–11. 10 indexed citations
7.
Sperandio, David, Anthony R. Gangloff, Joane Litvak, et al.. (2002). Highly potent non-peptidic inhibitors of the HCV NS3/NS4A serine protease. Bioorganic & Medicinal Chemistry Letters. 12(21). 3129–3133. 29 indexed citations
8.
Ho, Joseph D., Joseph J. Buggy, James T. Palmer, et al.. (2002). Expression, purification, crystallization and preliminary X-ray diffraction studies of human cathepsin F complexed with an irreversible vinyl sulfone inhibitor. Acta Crystallographica Section D Biological Crystallography. 58(12). 2187–2190. 7 indexed citations
9.
Katz, B.A., Paul A. Sprengeler, Christine Luong, et al.. (2001). Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets. Chemistry & Biology. 8(11). 1107–1121. 51 indexed citations
10.
Katz, B.A., Kyle Elrod, Christine Luong, et al.. (2001). A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site11Edited by D. Rees. Journal of Molecular Biology. 307(5). 1451–1486. 61 indexed citations
11.
Young, Wendy B., Aleksandr Kolesnikov, Roopa Rai, et al.. (2001). Optimization of a screening lead for factor VIIa/TF. Bioorganic & Medicinal Chemistry Letters. 11(17). 2253–2256. 39 indexed citations
12.
Rai, Roopa, Aleksandr Kolesnikov, Yong Li, et al.. (2001). Development of potent and selective factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(14). 1797–1800. 7 indexed citations
13.
Shrader, William D., Wendy B. Young, Paul A. Sprengeler, et al.. (2001). Neutral inhibitors of the serine protease factor Xa. Bioorganic & Medicinal Chemistry Letters. 11(14). 1801–1804. 19 indexed citations
14.
Dhanak, Dashyant, George Burton, Michael G. Darcy, et al.. (2000). Metal mediated protease inhibition: design and synthesis of inhibitors of the human cytomegalovirus (hCMV) protease. Bioorganic & Medicinal Chemistry Letters. 10(20). 2279–2282. 10 indexed citations
15.
Kuzmič, Petr, Kyle Elrod, Lynne Cregar, et al.. (2000). High-Throughput Screening of Enzyme Inhibitors: Simultaneous Determination of Tight-Binding Inhibition Constants and Enzyme Concentration. Analytical Biochemistry. 286(1). 45–50. 47 indexed citations
16.
Kuzmič, Petr, Steve Sideris, Lynne Cregar, et al.. (2000). High-Throughput Screening of Enzyme Inhibitors: Automatic Determination of Tight-Binding Inhibition Constants. Analytical Biochemistry. 281(1). 62–67. 48 indexed citations
17.
Janc, James W., James M. Clark, Robert Warne, et al.. (2000). A Novel Approach to Serine Protease Inhibition:  Kinetic Characterization of Inhibitors Whose Potencies and Selectivities Are Dramatically Enhanced by Zinc(II). Biochemistry. 39(16). 4792–4800. 27 indexed citations
18.
Cregar, Lynne, Kyle Elrod, Daun Putnam, & William R. Moore. (1999). Neutrophil Myeloperoxidase Is a Potent and Selective Inhibitor of Mast Cell Tryptase. Archives of Biochemistry and Biophysics. 366(1). 125–130. 33 indexed citations
19.
Elrod, Kyle, et al.. (1999). Expression and Characterization of Recombinant Mast Cell Tryptase. Protein Expression and Purification. 15(3). 251–257. 10 indexed citations
20.
Elrod, Kyle, William R. Moore, William M. Abraham, & Richard D. Tanaka. (1997). Lactoferrin, a Potent Tryptase Inhibitor, Abolishes Late-Phase Airway Responses in Allergic Sheep. American Journal of Respiratory and Critical Care Medicine. 156(2). 375–381. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Austin Vogt Breakdown of academic impact, for papers by S. Maignan Breakdown of academic impact, for papers by Verónica Alcolea Breakdown of academic impact, for papers by J.P. Guilloteau Breakdown of academic impact, for papers by Igor Mochalkin Breakdown of academic impact, for papers by Mark Watson Breakdown of academic impact, for papers by Wentao Fu Breakdown of academic impact, for papers by Wolfgang von der Saal Breakdown of academic impact, for papers by J. Courtland White Breakdown of academic impact, for papers by Paulo Boschcov
Rankless by CCL
2026